Infrascanner Reduces TBI Treatment Times in Combat Settings

MEDIA, Pa., Sept. 29, 2026 /CourierPR/ -- A new study presented at the 2026 Military Health System Research Symposium (MHSRS) has demonstrated the potential of the Infrascanner, a portable brain injury assessment device, in reducing evacuation and surgical treatment times for patients with traumatic brain injury (TBI) in austere medical settings. The study, which evaluated the use of the Infrascanner in Ukraine, found significant reductions in evacuation and surgical times, with evacuation times reduced by 25 minutes to 2 hours and the use of the Infrascanner associated with a 47% reduction in time to surgery.

The study, which consisted of an initial 300-patient baseline phase followed by a 300-patient device phase completed in April 2026, found that the Infrascanner provided decision support for the diagnosis and screening of TBI in environments where access to CT imaging, neurosurgery, and rapid medical evacuation may be limited. The Infrascanner, a handheld screening device that utilizes near-infrared technology to assist in identifying intracranial bleeding following head trauma, was found to be 100% sensitive among patients who ultimately required neurosurgery.

The study also revealed that the Infrascanner contributed to a change in patient care among 88.5% of participating clinicians and was unanimously agreed upon by survey respondents as a technology needed at stabilization points and forward surgical teams. In polytrauma patients, the Infrascanner served as an adjunctive screening tool, alerting clinicians to abnormalities that developed later or had not been identified during earlier examinations. The study systems operated without reported device failures throughout the seven-month device phase, including in winter field conditions.

InfraScan, Inc., the medical device company that specializes in portable brain injury assessment technology, announced the completion of the study. The CEO of InfraScan, Dr. Baruch Ben Dor, stated that the results demonstrate the importance of rapid, portable brain assessment in combat and other austere medical environments. He added that when CT imaging and neurosurgical care may be hours away, providing clinicians with additional objective information at the point of care can help them make critical triage and evacuation decisions.

The Infrascanner is a portable screening device that uses near-infrared technology to help clinicians identify intracranial bleeding in patients with head trauma. Clinicians can complete a patient assessment within minutes, providing risk-stratification and decision-support information that may help them determine which patients require further evaluation, CT imaging, or escalation to a higher level of care.

The study was awarded through MTEC solicitation MTEC-24-01-MPAI and is funded by the DoD Combat Casualty Research Program (CCCRP) in accordance with the Congressional direction to establish military medical partnerships with Ukraine. The CCCRP has funded research projects related to traumatic brain injury, hemorrhage control, traumatic stress, rehabilitation, wound management, severe sepsis, and trauma registry development.

The Infrascanner technology has been developed with support from the U.S. military and has been used in civilian and military medical settings in the United States and internationally. The study's findings are particularly relevant to large-scale combat operations, where medical teams may face prolonged evacuation times, limited transportation resources, and delayed access to advanced diagnostic imaging.